MARKET WIRE NEWS
  1. Home
  2. Stock
  3. ACAD
  4. Message Board
  5. ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) Read Post Read Post 657710 - DAYBU (trofinetide) Recommended For Approval In The European
ACAD
Quote
Short
News
Articles
Message Board

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD Message Board Post 657710

Recent ACAD Posts
Posted By: (investorshub) @US Market News

Posted on: Jun/26/2026 11:00:19

DAYBU (trofinetide) Recommended for Approval in the European

Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177736296

Back to ACAD Board

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Message Board Posts

Recent ACAD Posts
investorshub : US Market News
Acadia Pharmaceuticals Announces Planned Year-End Retirement of Elizabeth
investorshub : US Market News
Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
investorshub : US Market News
Acadia Pharmaceuticals to Present Data at the 2026
investorshub : iHub News
Acadia launches powder version of Rett syndrome treatment

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.